Save the date! We invite you to join Oncology Nursing News for an #OncNurseConnect Tweet Chat on Thursday, February 27, at 1 p.m. EST, when we plan on discussing the popular topics in nursing covered in our latest issue.
Save the date! We invite you to join Oncology Nursing News for an #OncNurseConnect Tweet Chat on Thursday, February 27, at 1 p.m. EST, when we plan on discussing the popular topics in nursing covered in our February issue.
Each quarter, we host an #OncNurseConnect Tweet Chat to bring together nursing professionals and others in the cancer care space to promote collaboration within the community. This chat will be focused on popular topics in oncology nursing, from global healthcare to workplace diversity and more. During the chat, we’ll ask the following questions:
Never participated in a Tweet Chat before? It’s simple!
We'll see you on Twitter!
FDA Approves T-DXd for Previously Treated HER2-Low and -Ultralow Metastatic Breast Cancer
Published: January 27th 2025 | Updated: January 28th 2025T-DXd has received FDA approval for the treatment of unresectable or metastatic HR+, HER2-low/-ultralow breast cancer in patients whose disease progressed on prior endocrine therapy in the metastatic setting.
ctDNA Status May Be Prognostic for DFS With Celecoxib for Stage III Resected Colon Cancer
January 26th 2025While ctDNA positivity was linked to worse overall disease-free survival (DFS) in stage III resected colon cancer, it was associated with significantly improved DFS with celecoxib compared to placebo.